Diabetic Retinopathy Treatment

Global Market Trajectory & Analytics

MCP-6237

EXECUTIVE ENGAGEMENTS

POOL

3623
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

653
Interactions with Platform & by Email

PARTICIPANTS

109
Unique # Participated

VALIDATIONS

31
Responses Validated*

COMPANIES

40
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

207

PAGES

277

EDITION

15

PRICE

USD 5450

CODE

MCP-6237


COMPETITIVE METRICS

COMPANY

D S N T

% *

AstraZeneca PLC

Daiichi Sankyo Co., Ltd.

Eli Lilly and Company

F. Hoffmann-La Roche AG

Gene Signal International SA

Genentech, a Roche Company

Gp Pharm

Novartis International AG

Opko Health, Inc.

Pfizer, Inc.

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Diabetic Retinopathy Treatment estimated at US$6.8 Billion in the year 2020, is projected to reach a revised size of US$9.6 Billion by 2027, growing at aCAGR of 5.1% over the period 2020-2027. Proliferative Diabetic Retinopathy, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Proliferative Diabetic Retinopathy segment is readjusted to a revised 5.3% CAGR for the next 7-year period.
The Diabetic Retinopathy Treatment market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2027 trailing a CAGR of 7.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

SELECT PLAYERS

Alimera Sciences, Inc.; Allergan PLC; Ampio Pharmaceuticals, Inc.; BCN Peptides S.A.; Genentech, Inc.; Glycadia, Inc.; Kowa Co., Ltd.; Novartis International AG; Regeneron Pharmaceuticals, Inc.; Sirnaomics, Inc.

SEGMENTS

» Type (Proliferative Diabetic Retinopathy, and Non-Proliferative Diabetic Retinopathy) » Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, and Vitrectomy)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Diabetic Retinopathy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Diabetic Retinopathy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Diabetic Retinopathy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Proliferative Diabetic Retinopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Proliferative Diabetic Retinopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Proliferative Diabetic Retinopathy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Non-Proliferative Diabetic Retinopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Non-Proliferative Diabetic Retinopathy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Non-Proliferative Diabetic Retinopathy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Anti-VEGF by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Anti-VEGF by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Anti-VEGF by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Intraocular Steroid Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Intraocular Steroid Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Intraocular Steroid Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Laser Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Laser Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Vitrectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Vitrectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
China Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Diabetic Retinopathy Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Diabetic Retinopathy Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Diabetic Retinopathy Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
France Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Diabetic Retinopathy Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Diabetic Retinopathy Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Diabetic Retinopathy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
India Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Diabetic Retinopathy Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Diabetic Retinopathy Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Diabetic Retinopathy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Diabetic Retinopathy Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Diabetic Retinopathy Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Diabetic Retinopathy Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Diabetic Retinopathy Treatment by Type - Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Diabetic Retinopathy Treatment by Type - Percentage Breakdown of Value Sales for Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Diabetic Retinopathy Treatment by Management - Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Diabetic Retinopathy Treatment by Management - Percentage Breakdown of Value Sales for Anti-VEGF, Intraocular Steroid Injection, Laser Surgery and Vitrectomy for the Years 2012, 2020 & 2027
Total Companies Profiled: 40

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com